1） 内閣府 平成 26 版高齢社会白書（全体版）https://www8.cao.go.jp/kourei/whitepaper/w-2014/zenbun/26pdf_index.html
2） Okura Y, Ramadan M, Ohno Y, et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 2008; 72: 489-491.
3） 平成 26 年人口動態調査 年齢階級別死因別死亡数 https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai14/dl/kekka.pdf
4） 厚生労働省 平成 26 年度国民医療費の概要 https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/14/
5） 内閣府 平成 26 年社会保障給付費の推移 http://www.ipss.go.jp/ss-cost/j/fsss-h26/H26-houdougaiyou.pdf
6） Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, et al. Chronic kidney disease as an independent risk for long-term adverse outcome in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 1442-1447.
7） Shiba N, Matsuki M, Takahashi J, et al. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J 2008; 72: 173-178.
8） Shimokawa H, Miura M, Nochika K, et al. Heart failure as a general pandemic in Asia. Eur J Heart Fail. 2015; 17: 884-892.
9） Astor BC, Matsushita K, Gansevoort RT, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79:1331-1340.
10） Ninomiya T, Kiyohara Y, Tokuda Y, et al. Impact of kidney disease and blood pressure on the development of Cardiovascular disease: an overview from the Japan arteriosclerosis Longitudinal study. Circulation 2008; 118: 2694-2701.
11） Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621-630.
12） Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Nihon Jinzo Gakkai Shi 2012; 54: 1034-1191.
13） Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, et al. Chronic kidney disease as an independent risk for long-term adverse outcome in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 1442-1447.
14） Go AS, Chertow GM, Fan D, et al. Chonic kidney disease and the risks of death, cardiovascular events, and Hospitalization. N Engl J Med 2004; 351: 1296-1305.
15） Keith S, Gregory A, Chistina M, et al. Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization. Arch Intern Med 2004;164: 659-663.
16） Ronco C, Happio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.
17） Toyama K, Sugiyama S, Oka H, et al. Exercise therapy correlates with improving renal function through modifying lipid metabolism in patients with cardiovascular disease and chronic kidney disease. J Card 2010; 56:142-146.
18） Takaya Y, Kumasaka R, Arakawa T, et al. Impact of Cardiac Rehabilitation on Renal Function in Patients with and without Chonic Kindney Disease After Acute Myocardial Infarction. Circ J 2014; 78: 377-384.
19） Kimura S, Ueda Y, Ise T, et al. Impact of Supervised Cardiac Rehabilitation on Urinary Albumin Excretion in Patients With Cardiovascular Disease. In Heart J 2015; 55 :105- 109.
20） Iso Y, Kitai H, Kowaita H, et al. Association of aging with glomerular filtration changes in cardiac rehabilitation participants with chronic kidney disease. Int J Card 2015;187: 283-285.
21） Patel SS, Kalantar-Zadeh K, Molnar MZ,et al. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle 2013;4:19-29.
22） Alessandre CB, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008; 3: 348-354.
23） 谷本芳美, 渡辺美鈴, 河野令ら．日本人筋肉量の加齢による特徴．日本老年医学会 2010; 40: 52-57.
24） Jablonski KL, Chonchol M. Cystatin-C-based eGFR: what is it telling us? Nat Rev Nephrol 2013; 9: 318-319.
25） Tanaka A,Suemaru K, Araki H, et al: A new approach for evaluating renal function and its practical application, J Pharmacol Sci 2007; 105: 1-5.
26） Mingels A, Jacobs L, Kleijnen V, et al. Cystatin C a marker for renal function after exercise. Int J Sports Med 2009; 30: 668-71.
27） Laterza OF, Price CP, Scott MG, Cystatin C. An improved estimator of glomerular filtration rate? Clin Chem 2002; 48: 699-707.
28） Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J kidney Dis 2001; 37: 79-83.
29） Garasto S, Fusco S, Corica F, et al. Estimating Glomerular Filtration Rate in Older People. Biomed Res Int. 2014. 916542. doi: 10.1155/2014/916542.
30） Maharajan R, Middleton RJ, Kalra PA, et al. Estimating renal function in old people: an in‑depth review. Int Urol Nephrol 2017; 49: 1979-1988.
31） Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kindey Dis 2002; 40 : 221-226.
32） Shastri S, Katz R, Rifkin DE, et al. Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars. J Am Geriatr Soc 2012; 60: 1201-1207.
33） 上月正博、後藤洋一．日本腎臓リハビリテーション学会・日本心臓リハビリテーション学会からの共同ステートメント：骨格筋量低値患者または運動療法実施患者における推定糸球体濾過量(eGFR)による腎機能評価について． https://jsrr.jimdo.com/心臓リハビリテーション学会との共同ステートメント.
34） Hama T, Oikawa K, Ushijima A, et al. Effect of cardiac rehabilitation on the renal function in chronic kidney disease - Analysis using serum cystatin-C based glomerular filtration rate. Int J Cardiol Heart Vasc 2018;19: 27-33.
35） Wen CP, Wai JP, Tsai MK, et al: Minimum amount of physical activity for reduced mortality and extended life expectancy: A prospective cohort study. Lancet 2011; 378: 1244-1253.
36） Sato T, Kohzuki M, Ono M, et al. Association between physical activity and change in renal function in patients after acute myocardial infarction. PLOS ONE 2019; 14: e0212100. doi: 10.1371/journal.pone.0212100.
37） Robinson-Cohen C, Katz R, Dariush M, et al. Physical activity and rapid decline in kidney function among older adults. Arch Intern Med 2009; 169: 2116-2123.
38） Dibben G, Dala HM, Taylor RS, et al. Cardiac rehabilitation and physical activity: systematic review and meta-analysis. Heart 2018; 104: 1394-1402.
39） JCS Joint Working Group. Guidelines for Rehabilitation in Patients with Cardiovascular Disease（JCS 2012）.Circ J 2014;78: 2022-2093.
40） Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training; a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-1740.
41） American Association of Cardiovascular and Pulmonary Rehabilitation. 2004. Guideline for cardiac rehabilitation and secondary prevention program. 4th ed.
42） 日本心臓リハビリテーション学会 心不全の心臓リハビリテーション標準プログラム 2017.
43） American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998; 30: 975-991.
44） Rhea MR, Alvar BA, Burkett LN, et al. A meta-analysis to determin the dose response for strength development. Med Sci Sports Exerc 1999; 35: 456-464.
45） Feigenbaum MS, Pollock ML. Prescription of resistance training for health and disease. Med Sci Sports Exerc 1999; 31: 38-45.
46） Davidson PM, Cockburn J, Newton PJ, et al. Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients? Eur J Cardiovasc Prev Rehabil 2010;7393-7402.
47） Horio M, Imai E, Yasuda Y, et al. Collaborators Developing the Japanese Equation for Estimated GFR. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis 2013; 61: 197-203.
48） Matsuo S, Imai E, Horio M, et al. Revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
49） Crapo RO, Casaburi R, Coates AL, et al. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 1111-1117.
50） James E, Ostir GV, Fisher SR, et al. Assessing walking speed in clinical research: a systematic review. Journal of Evaluation in Clinical Practice 2008;14: 552-562.
51） Reddon JR, Stefnayk WO, Gill DM, et al. Hand dynamometer: effects of trials and sessions. Percept Mot Skills 1985; 61:1195-1198.
52） Marta W, Wilinski W, Struzik A, et al. Hand Grip Strength Vs. Sprint Effectiveness in Amputee Soccer Players. Journal of Human Kinetics volume 2015; 48: 133-139.
53） Yoon TS, Park SW, Kang SW, et al. Isometric and isokinetic torque curves at the knee joint. Yonsei Medical Journal 1991; 32: 33-43．
54） Pincivero DM, Salfetnikov Y, Campy RM, et al. Angle- and gender-specific quadriceps femoris muscle recruitment and knee extensor torque. J Biomech 2004; 37: 1689-1697.
55） McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the Heart and Soul study). Am J Cardiol 2005; 96: 1076- 1081.
56） 村松公美子，宮岡等，上島国利．プライマリケアにおけるうつ病スクリーニングに有用な評価ツール －Patient Health Questionaire（PHQ）-9 について－．精神科治療学 2008; 23: 1299-1306.
57） Aoyagi Y, Park H, Watanabe E, et al. Habitual physical activity and physical fitness in older Japanese adults: the Nakanojo study. Gerontology 2009; 55: 523–531.
58） Sabrina S, Natasha W, Linda F, et al.Statins for Improving Renal Outcomes: A Meta- Analysis. JASN 2006; 17: 2006-2016.
59） Qiang G, Jingyi R, Junxian S, et al. Meta-Analysis of the Effect of Statins on Renal Function. Am. J. Cardiol 2014; 15: 562-570.
60） Stefan H, Marina S, Maria H, et al. Exercise‐based cardiac rehabilitation is associated with a normalization of the heart rate performance curve deflection. Scand J Med Sci Sports 2019; 29: 1364-1374.
61） Stuart E, Grace L, Sandra W, et al. Early initiation of post-sternotomy cardiac rehabilitation exercise training (SCAR): study protocol for a randomized controlled trial and economic evaluation. BMJ Open 2018. http://dx.doi.org/10.1136/bmjopen-2017- 019748.
62） Yamagata K, Takahashi H, Suzuki S, et al. Age distribution and yearly changes in the incidence of ESRD in Japan. Am J Kidney Dis 2004; 43: 433-443.
63） Imai E, Horio M, Yamagata K, et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 2008; 31: 433-441.
64） Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet. 2001; 357: 1601-1608.
65） Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000; 58: 293- 301.
66） Iseki K, Oshiro S, Tozawa M, et al. Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan. Hypertens Res 2002; 25: 185-190.
67） Roshanravan B, Robinson-Cohen C, Patel K, et al. Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol 2013; 24: 822-830.
68） Shepherd J, Breazna A, Deedwania PC, et al. Relation between change in renal function and cardiovascular outcomesin atorvastatin-treated patients (from the Treating to New Targets [TNT] Study). Am J Cardiol 2016; 117: 1199-1205.
69） Posma RA, Lexis CP, Lipsic E, et al. Effect of metformin on renal function after primary percutaneous coronary intervention in patients without diabetes presenting with ST-elevation myocardial infarction: data from the GIPS-III trial. Cardiovasc Drugs Ther 2015; 29: 451-459.
70） Kitajima K, Fujimi K, Matsuda T, et al. Possibility of Cardio-renal Protection by Long- term Cardiac Rehabilitation in Elderly Patients with Cardiovascular Diseases. Intern Med 2019; 58: 2133-2138.
71） Greenwood SA, Koufaki P, Mercer TH, et al. Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am J Kidney Dis. 2015; 65 :425-34.
72） Lijun Zhang, et al. Exercise therapy improves eGFR, and reduces blood pressure and BMI in non-dialysis CKD patients: evidence from a meta-analysis. BMC Nephrology 2019; 20: 398.
73） Imai E, Horio M, Yamagata K, et al. Slower decline of glomerular filtration rate in the Japanese general population：A longitudinal 10 - year follow - up study. Hypertens Res 2008; 31: 433 - 441
74） Barai S, Gambhir S, Prasad N, et al. Functional renal reserve capacity in different stages of chronic kidney disease. Nephrology 2010; 15: 350-353.
75） Gerald F, Carolyn L, Josef N, et al. Promoting Physical Activity and Exercise JACC Health Promotion Series. J Am Coll Cardiol 2018; 72: 1622-1632.
76） Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non- communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380: 219-229.
77） King AC, Haskell W, Young D, et al. Stefanick Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years Circulation 1995; 91: 2596-2604.
78） Kraus W, Houmard J, Duscha B, et al. Effects of the amount and intensity of exercise on plasma lipoproteins N Engl J Med 2002; 374: 1483-1492.
79） Stevenson E, Davy K, Seals D. Hemostatic, metabolic, and androgenic risk factors for coronary heart disease in physically active and less active postmenopausal women Arterioscler Thromb Vase Biol 1995; 15: 669-677.
80） Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med 2010; 14: 397-415.
81） Ishida T, Miura S, Fujimi K, et al. Visit-to-Visit Variability and Reduction in Blood Pressure After a 3-Month Cardiac Rehabilitation Program in Patients With Cardiovascular Disease. Int Heart J 2016; 57:607-614.
82） George A, Kristi S, Barry F. Aerobic Exercise and Lipids and Lipoproteins in Patients With Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials. J Cardiopulm Rehabil 2006; 26: 131-144.
83） Manttari M, Tinla E, Alikoski T, et al. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995; 26: 670-675.
84） Koba S, Ayaori M, Uto-Kondo H, et al. Beneficial Effects of Exercise-Based Cardiac Rehabilitation on High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity in Patients with Acute Coronary Syndrome. J Atheroscler Thromb. 2016; 23 :865-877.
85） 日本腎臓学会. CKD 診療ガイド 2012. Index1-3.
86） Bristow MR, Gilbert EM, Abraham K, et al . : For the MOCHA Investigators. Carvedilol produces doserelated improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996; 94: 2807-2816.
87） Packer M, Coats AJ, Fowler MB, et al . : Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
88） The CAPRICORN investigators : Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction ; the CAPRICORN randomized trial. Lancet 2001; 357: 1385-1390.
89） Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med 2008; 359: 2417-2428.
90） Barkris GL, Sarafidis PA, Weir MR, et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trialLancet. 2010; 375: 1173-1181.
91） Muramatsu K, Miyaoka H, Kamijima K, et al. The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep 2007; 101: 952-60.
92） Van Melle JP, De Jonge P, Spijkerman TA, et al.: Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a metaanalysis. Psychosom Med 2004; 66: 814-822.
93） Havranek EP, Spertus JA, Frederick AM, et al.: Predictors of the onset of depressive symptoms in patients with heart failure. J American College of Cardiology 2004; 44: 2333-2338.
94） Nishitani M, Shimada K, Masaki M, et al. Effect of cardiac rehabilitation on muscle mass, muscle strength, and exercise tolerance in diabetic patients after coronary artery bypass grafting. Journal of cardiology 2013; 6: 216-221.
95） Yoichiro O, Hiroki T, Tetsu W,et al. Cystatin C-Based eGFR Is a Superior Prognostic Parameter to Creatinine-Based eGFR in Post-Endovascular Therapy Peripheral Artery Disease Patients. Circ J 2015; 79: 2480–2486.
96） Mark C, Donal JS, Matthew DL, et al. Kidney Function Estimated From Cystatin C, But Not Creatinine, Is Related to Objective Tests of Physical Performance in Community- Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2017; 72: 1554–1560.
97） Shlipak MG, Matsushita K, Ärnlöv J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013;369: 932-943.
98） Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. New England Journal of Medicine. 2005; 352: 2049-2060.
99） Hood B, Attman PO, Ahlmén J, et al. Renal hemodynamics and limitations of creatinine clearance in determining filtration rate in glomerular disease. Scandinavian Journal of Urology and Nephrology 1971; 5: 154–161.
100） Horio M, Imai Y, Yasuda Y, et al. Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance. Clin Exp Nephrol 2011; 15: 868-876.
101） Goto Y. Current state of cardiac rehabilitation in Japan. Prog cardiovasc 2014; 56: 557-562.
102） Arakawa T, Kumasaka L, Nakanishi M, et al. Regional Clinical Alliance Path and Cardiac Rehabilitation After Hospital Discharge for Acute Myocardial Infarction Patients in Japan – A Nationwide Survey –. Circ J 2016; 80: 1750-1755.
103） Kohzuki M. Late Phase II Cardiac Rehabilitation, Which Is Adding Life to Years and Years to Life, Is Still Underused in Japan. Circ J 2016; 80:1697-1699.
104） Kamiya K, Yamamoto T, Makaya MT, et al. Nationwide Survey of Multidisciplinary Care and Cardiac Rehabilitation for Patients With Heart Failure in Japan - An Analysis of the AMED-CHF Study.Circ J 2019; 83: 1546-1552.
105） Endo N, Goto A, Suzuki T, et al. Factors associated with enrollment and adherence in outpatient cardiac rehabilitation in Japan. J cardiopulm rehabil prev 2015; 35 :186-192.
106） Endo N, Goto A, Suzuki T, et al. Exploring the Effect of Outpatient Cardiac Rehabilitation on Prevention of Short-term Re-admission: A Hospital-based Study in Fukushima, Japan. Journal of General and Family Medicine 2016; 17: 170-173.
論文の公開元へ
